Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Making Medicare Like Medicaid: High Anxiety For Drug Makers

Executive Summary

While there's no active proposal on the table in Congress for Medicare to adopt Medicaid-like pricing, given the US election year uncertainties and the current increased focus on drug pricing, analysts insisted that although such a scenario represented the worst case, it's the most reasonably realistic situation under which the government could try to rein in spending on prescription medicines.


Related Content

Analysts: Xtandi March-In Demands 'Noise,' 'Misguided'
PhRMA Condemns Medicare B Rx Drug Payment Experiment


Related Companies